SAMF vs Anesthesiologists

Regarded as the gold standard of medicines information and clinical management protocols in South Africa, the South African Medicines Formulary (SAMF), first published in 1988, is a trusted source of information and provides up-to-date, reliable, unbiased and evaluated information on medicines. Currently on its 15th edition , it has become a standard health practitioner's medicine reference guide, respected for accuracy of content and independence from the pharmaceutical industry. It is now available on this mobile application and supported by a web portal (https://samf-app.com/) which subscribers will have access to. The SAMF application and Book is a joint initiative of the Division of Clinical Pharmacology at the University of Cape Town and the South African Medical Association (SAMA). Liquid thought maintains the application and web portal. To find information on each of the entities : - Medicines Information Centre, Division of Clinical Pharmacology at the University of Cape Town: http://www.mic.uct.ac.za - South African Medical Association: https://www.samedical.org - Liquid thought: https://www.liquidthought.co.za All content provided in the Platform is for informational, educational and assistive purposes only, and is not a substitute for the professional judgement of healthcare professionals diagnosing and treating patients. UCT and SAMA do not provide medical advice or medical or diagnostic services through the Platform. Any reliance on the content obtained on or through the Platform is at your own risk. SAMF Citation: - Division of Clinical Pharmacology, Faculty of Health Sciences. (2024). South African Medicines Formulary (SAMF). SAMF website. https://samf-app.com Get access to SAMF app content with an in-app purchase. There are 2 subscription options to choose from: - 1 month subscription costs R93.99 (Prices may vary slightly depending on location) - 1 year subscription costs R929.99 (Prices may vary slightly depending on location) Payment will be made at the time of purchase confirmation via your App Store account The subscription will be automatically extended if you do not switch off the automatic renewal at least 24 hours before the premium membership expires

Anesthesiologist is designed to help quickly calculate adult and pediatric anesthesia related information. Useful for anesthesiologists, CRNA, ER and critical care physicians, as well as medical students, residents, and fellows. Drug dosing and airway management information is calculated on the basis of patient weight and age. The app is a work in progress; please see "What's new" for updates about included information. Airway: Mask size Laryngoscope blade size Endotracheal tube size Laryngeal mask airway (LMA) size and ETT it will admit Drugs including IM and rapid sequence induction dosing: Succinylcholine Rocuronium Cisatracurium Vecuronium Propofol Etomidate Ketamine Thiopental Fentanyl Hydromorphone Morphine Ketorolac Acetaminophen Ondansetron Dexamethasone Metoclopramide Epinephrine Amiodarone Phenylephrine Ephedrine Midazolam Clonidine Glycopyrrolate Atropine Neostigmine Cefazolin Ceftriaxone Ampicillin Cefoxitin Clindamycin Gentamicin Vancomycin Infusions: Remifentanil Propofol Dopamine Dobutamine Epinephrine Isoproterenol Norepinephrine Milrinone Phenylephrine Vasopressin Nitroglycerin Nitroprusside Esmolol Obstetric drugs: Magnesium Oxytocin Methergine Carboprost (Hemabate) Terbutaline Copyright 2011 Vikas Shah. Disclaimer and warning: This application was written solely to be used as a helpful adjunct for professionally trained physicians and practitioners otherwise experienced in airway management and drug administration and dosing. The data is provided for informational purposes only and in no way should be construed as professional medical advice. If you don't know the drug, its side effects, and its pitfalls, don't use it! Care has been taken that no errors in calculation have been made, but all calculations must be verified by the user. Drug dosing given here is based on published doses, but in all cases drugs should be administered on a case by case basis and titrated to effect for the individual patient. In no case have individual patient differences been taken into account, and conditions including but not limited to renal disease, hepatic dysfunction, cardiovascular disease, pulmonary disease, metabolic diseases and mitochondrial diseases may impact dosing or safety in the use certain drugs. Neither the name of the copyright owner nor the name of this project may be used to endorse or promote products derived from this software without specific prior written permission. This software is provided by the copyright holder "as is" and any express or implied warranties, including, but not limited to, the implied warranties of merchantability and fitness for a particular purpose are disclaimed. In no event shall the copyright owner be liable for any direct, indirect, incidental, special, exemplary, or consequential damages (including, but not limited to, procurement of substitute goods or services; loss of use, data, or profits; or business interruption) however caused and on any theory of liability, whether in contract, strict liability, or tort (including negligence or otherwise) arising in any way out of the use of this software, even if advised of the possibility of such damage. In places where such liabilities cannot be waived or disclaimed, liability shall not exceed the retail cost of the application to the user of the application. Use of this app implies agreement to these terms and conditons. If you do not agree with these terms and conditions, delete this applicaton from your device.